| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $124.4M | +6.5% |
| Cost of Revenue | $90.5M | +4.3% |
| Gross Profit | $33.9M | +12.6% |
| R&D Expense | $1.7M | +0.9% |
| SG&A Expense | $11.7M | +3.7% |
| Operating Income | $8.4M | +22.7% |
| Pre-tax Income | $8.3M | +26.6% |
| Income Tax | $2.2M | +111.0% |
| Net Income | $6.1M |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.5M | -25.4% |
| Accounts Receivable | $11.9M | -12.3% |
| Inventory | $19.8M | +1.4% |
| Current Assets | $51.2M | -9.3% |
| Total Assets | $86.8M | -6.5% |
| Current Liabilities | $18.4M | -39.5% |
| Long-term Debt | $35K | -28.6% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$113K | -106.5% |
| Capital Expenditures | $518K | -42.6% |
| Investing Cash Flow | -$4.9M | -419.9% |
| Financing Cash Flow | $104K | +101.0% |
| Free Cash Flow | -$631K | -176.3% |
| -76.7% |
| EPS (Basic) | $0.20 | -76.5% |
| EPS (Diluted) | $0.19 | -77.1% |
| Total Liabilities |
| $21.7M |
| -37.5% |
| Stockholders' Equity | $65.1M | +12.1% |